Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corabotase in Cervical Dystonia
NCT06937931Phase 2Recruiting
- Sponsor
- Ipsen
- Start
- Jun 2025
- Primary completion
- Mar 2027
- Modality
- Therapeutic Enzymes
- Countries
- 8
01
Overview
Phase 2, randomised, double-blind trial of corabotase in cervical dystonia (CD) (5 arms), sponsored by Ipsen. Primary endpoint: Toronto Western Spasmodic Torticollis Rating Scale Total at 4 weeks. Started Jun 2025; status: recruiting.
02
Drugs
corabotase
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT06937931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06937931.